Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZBTB39 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPR182 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYO1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RDH16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDR9C7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAT6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRIM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NACA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on